- Home
- ZYME vs GTY Comparison
ZYME vs GTY Comparison
Compare ZYME & GTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZYME | GTY |
|---|---|---|
| Founded | 2003 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZYME | GTY |
|---|---|---|
| Price | $25.80 | $28.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | $28.50 | ★ $31.80 |
| AVG Volume (30 Days) | ★ 1.8M | 353.3K |
| Earning Date | 11-06-2025 | 10-22-2025 |
| Dividend Yield | N/A | ★ 6.85% |
| EPS Growth | N/A | ★ 10.25 |
| EPS | N/A | ★ 1.28 |
| Revenue | $134,481,000.00 | ★ $214,194,000.00 |
| Revenue This Year | $64.45 | $6.23 |
| Revenue Next Year | $67.04 | $8.82 |
| P/E Ratio | ★ N/A | $22.18 |
| Revenue Growth | ★ 116.21 | 8.17 |
| 52 Week Low | $9.03 | $25.39 |
| 52 Week High | $28.49 | $32.64 |
Technical Indicators
Market Signals| Indicator | ZYME | GTY |
|---|---|---|
| Relative Strength Index (RSI) | 63.18 | 55.12 |
| Support Level | $24.83 | $27.63 |
| Resistance Level | $27.49 | $28.66 |
| Average True Range (ATR) | 1.32 | 0.43 |
| MACD | -0.03 | -0.06 |
| Stochastic Oscillator | 60.00 | 55.83 |
Price Performance
Historical ComparisonAbout ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About GTY Getty Realty Corporation
Getty Realty Corp is the real estate investment trust in the U.S. specializing in the acquisition, financing, and development of convenience, automotive, and other single tenant retail real estate. The company's portfolio includes convenience stores, car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, collision), automotive parts retailers, and certain other freestanding retail properties, including drive-thru quick service restaurants. It generates majority of the revenue in the form of rental income.